US Stock MarketDetailed Quotes

LXRX Lexicon Pharmaceuticals

Watchlist
  • 1.610
  • +0.030+1.90%
Close Oct 2 16:00 ET
  • 1.640
  • +0.030+1.86%
Post 17:12 ET
582.00MMarket Cap-2064P/E (TTM)

Lexicon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
419.56%1.65M
4,608.33%1.13M
766.19%1.2M
2,407.14%702K
315.38%162K
805.71%317K
-35.14%24K
-53.36%139K
100.00%28K
69.57%39K
Operating revenue
419.56%1.65M
4,608.33%1.13M
766.19%1.2M
2,407.14%702K
315.38%162K
805.71%317K
-35.14%24K
-53.36%139K
100.00%28K
69.57%39K
Cost of revenue
1,975.00%166K
31K
85K
70K
7K
8K
0
0
0
0
Gross profit
379.29%1.48M
4,479.17%1.1M
705.04%1.12M
2,157.14%632K
297.44%155K
782.86%309K
24K
-53.36%139K
28K
39K
Operating expense
27.58%56.84M
48.98%46.43M
71.33%172.87M
56.30%47.37M
115.21%49.79M
85.30%44.55M
33.09%31.17M
15.46%100.9M
19.58%30.31M
0.65%23.13M
Selling and administrative expenses
30.61%39.19M
67.50%32.06M
137.05%113.98M
99.69%32.61M
156.25%32.23M
180.82%30.01M
125.42%19.14M
48.67%48.08M
84.59%16.33M
72.22%12.58M
-General and administrative expense
----
67.50%32.06M
----
----
156.25%32.23M
----
125.42%19.14M
----
----
72.22%12.58M
Research and development costs
21.33%17.64M
19.51%14.37M
11.49%58.89M
5.62%14.76M
66.32%17.56M
8.87%14.54M
-19.43%12.03M
-4.05%52.82M
-15.28%13.98M
-32.68%10.56M
Operating profit
-25.12%-55.35M
-45.57%-45.33M
-70.45%-171.75M
-54.36%-46.74M
-114.90%-49.63M
-84.28%-44.24M
-33.20%-31.14M
-15.70%-100.76M
-19.53%-30.28M
-0.58%-23.1M
Net non-operating interest income expense
389.91%1.93M
-286.87%-3.06M
-353.46%-5.37M
-1,297.69%-3.02M
-206.16%-894K
-14.48%-664K
-725.00%-792K
-77.25%-1.18M
23.13%-216K
-82.50%-292K
Non-operating interest income
219.14%4.14M
83.09%1.88M
384.46%7.73M
170.80%2.4M
425.35%3.01M
953.66%1.3M
7,250.00%1.03M
1,091.04%1.6M
6,235.71%887K
5,100.00%572K
Non-operating interest expense
12.81%2.21M
171.72%4.95M
371.26%13.1M
391.48%5.42M
351.27%3.9M
178.81%1.96M
1,555.45%1.82M
246.63%2.78M
273.90%1.1M
405.26%864K
Other net income (expense)
Income before tax
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
Income tax
Net income
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
Net income continuous Operations
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
Minority interest income
Net income attributable to the parent company
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-18.98%-53.43M
-51.55%-48.4M
-73.74%-177.12M
-63.17%-49.76M
-116.04%-50.53M
-82.63%-44.9M
-36.03%-31.93M
-16.16%-101.94M
-19.07%-30.49M
-1.15%-23.39M
Basic earnings per share
22.73%-0.17
-17.65%-0.2
-29.03%-0.8
-25.00%-0.2
-61.54%-0.21
-37.50%-0.22
-6.25%-0.17
-3.33%-0.62
5.88%-0.16
18.75%-0.13
Diluted earnings per share
22.73%-0.17
-17.65%-0.2
-29.03%-0.8
-25.00%-0.2
-61.54%-0.21
-37.50%-0.22
-6.25%-0.17
-3.33%-0.62
5.88%-0.16
18.75%-0.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 419.56%1.65M4,608.33%1.13M766.19%1.2M2,407.14%702K315.38%162K805.71%317K-35.14%24K-53.36%139K100.00%28K69.57%39K
Operating revenue 419.56%1.65M4,608.33%1.13M766.19%1.2M2,407.14%702K315.38%162K805.71%317K-35.14%24K-53.36%139K100.00%28K69.57%39K
Cost of revenue 1,975.00%166K31K85K70K7K8K0000
Gross profit 379.29%1.48M4,479.17%1.1M705.04%1.12M2,157.14%632K297.44%155K782.86%309K24K-53.36%139K28K39K
Operating expense 27.58%56.84M48.98%46.43M71.33%172.87M56.30%47.37M115.21%49.79M85.30%44.55M33.09%31.17M15.46%100.9M19.58%30.31M0.65%23.13M
Selling and administrative expenses 30.61%39.19M67.50%32.06M137.05%113.98M99.69%32.61M156.25%32.23M180.82%30.01M125.42%19.14M48.67%48.08M84.59%16.33M72.22%12.58M
-General and administrative expense ----67.50%32.06M--------156.25%32.23M----125.42%19.14M--------72.22%12.58M
Research and development costs 21.33%17.64M19.51%14.37M11.49%58.89M5.62%14.76M66.32%17.56M8.87%14.54M-19.43%12.03M-4.05%52.82M-15.28%13.98M-32.68%10.56M
Operating profit -25.12%-55.35M-45.57%-45.33M-70.45%-171.75M-54.36%-46.74M-114.90%-49.63M-84.28%-44.24M-33.20%-31.14M-15.70%-100.76M-19.53%-30.28M-0.58%-23.1M
Net non-operating interest income expense 389.91%1.93M-286.87%-3.06M-353.46%-5.37M-1,297.69%-3.02M-206.16%-894K-14.48%-664K-725.00%-792K-77.25%-1.18M23.13%-216K-82.50%-292K
Non-operating interest income 219.14%4.14M83.09%1.88M384.46%7.73M170.80%2.4M425.35%3.01M953.66%1.3M7,250.00%1.03M1,091.04%1.6M6,235.71%887K5,100.00%572K
Non-operating interest expense 12.81%2.21M171.72%4.95M371.26%13.1M391.48%5.42M351.27%3.9M178.81%1.96M1,555.45%1.82M246.63%2.78M273.90%1.1M405.26%864K
Other net income (expense)
Income before tax -18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M
Income tax
Net income -18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M
Net income continuous Operations -18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M
Minority interest income
Net income attributable to the parent company -18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -18.98%-53.43M-51.55%-48.4M-73.74%-177.12M-63.17%-49.76M-116.04%-50.53M-82.63%-44.9M-36.03%-31.93M-16.16%-101.94M-19.07%-30.49M-1.15%-23.39M
Basic earnings per share 22.73%-0.17-17.65%-0.2-29.03%-0.8-25.00%-0.2-61.54%-0.21-37.50%-0.22-6.25%-0.17-3.33%-0.625.88%-0.1618.75%-0.13
Diluted earnings per share 22.73%-0.17-17.65%-0.2-29.03%-0.8-25.00%-0.2-61.54%-0.21-37.50%-0.22-6.25%-0.17-3.33%-0.625.88%-0.1618.75%-0.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data